Drug Discovery
Nautilus, Aventis enter collaboration to improve vaccine productivity
Published in Vaccine Weekly, October 30th, 2002
Nautilus' high throughput Platform Biomics is suited to develop high producer specific cell clones to improve productivity for either vaccines or proteins.
Under the terms of the agreement, Nautilus will receive full research funding, milestone payments, and royalty payments on product sales. Aventis Pasteur will receive exclusive worldwide rights to use the cell lines selected by Nautilus Biotech to manufacture and commercialize the vaccines.
"The improvement of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2002-10-30)
More Articles from Vaccine Weekly
- Genomics and Genetics Vaccine
Oral buccal delivery of antigen from adhesive polymer film successful in rabbits - Meningitis Vaccine
Neisseria meningitidis membrane protein elicits strong immune response - Cancer Vaccine
Tumor-specific IgM response to melanoma vaccine therapy indicates improved prognosis - Candida albicans
Some anti-C. albicans antibodies can reduce protective vaccine effects - Malaria Vaccine
Antimalaria toxin vaccine prevents severe adverse effects and death in mice - Pertussis Vaccine
Whooping cough incidence increasing among French adults - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
